Growth PotentialTeva aims to double its innovative brand sales by 2030, indicating strong growth potential.
Innovative PipelineTeva's innovative pipeline, including the Olanzapine LAI opportunity, could address a large unmet need driving significant potential global sales.
Product DevelopmentDuvakitug and olanzapine LAI represent multi-billion product opportunities, and TEVA is expected to highlight its broader R&D portfolio.